Peptide Libraray

H193W

General Information

DCTPep ID DCTPep00846

Peptide Name H193W

Sequence GCRLYGFKIWGG

Sequence Length 12

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

ACP Tumor active peptide Cancer targeted peptides

Activity Information

Cell Line	Disease	Activity	Assay	Testing Time	Literature
Hep-G2	Hepatoblastoma; Hepatoblastoma	IC50=19.4 µM	CCK-8 assay	48h	1

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Protein kinase CK2

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Cyclic

Disulfide/Other Bond Cys2<--->Cys12

N-terminal Modification Free

C-terminal Modification Free

Other Modification None

Chiral L

Physicochemical Information

Formula C64H93N17O14S1

Absent amino acids ADEHMNPQSTV

Theoretical pI 9.31

Acidic residues 0

Basic residues 2

Polar residues 6

Molecular weight (Average) 1356.61

Molecular weight (Monoisotopic) 1355.68

Common amino acids G

Net charge 2

Instability index (II) -15.87

Aliphatic index 65.00

Grand average of hydropathicity (GRAVY) 0.117

Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 6990
Abs 0.1% (=1 g/l) 5.153, assuming all pairs of Cys residues form cystines
Ext. coefficient 6990
Abs 0.1% (=1 g/l) 5.153, assuming all Cys residues are reduced

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 30307134

Title Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity

Doi 10.1002/minf.201800089

Year 2018

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available